| pubmed-article:7595699 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:7595699 | lifeskim:mentions | umls-concept:C0008059 | lld:lifeskim |
| pubmed-article:7595699 | lifeskim:mentions | umls-concept:C0013216 | lld:lifeskim |
| pubmed-article:7595699 | lifeskim:mentions | umls-concept:C0023449 | lld:lifeskim |
| pubmed-article:7595699 | lifeskim:mentions | umls-concept:C0927232 | lld:lifeskim |
| pubmed-article:7595699 | lifeskim:mentions | umls-concept:C0205527 | lld:lifeskim |
| pubmed-article:7595699 | lifeskim:mentions | umls-concept:C0025677 | lld:lifeskim |
| pubmed-article:7595699 | lifeskim:mentions | umls-concept:C0035020 | lld:lifeskim |
| pubmed-article:7595699 | lifeskim:mentions | umls-concept:C0079172 | lld:lifeskim |
| pubmed-article:7595699 | lifeskim:mentions | umls-concept:C1708528 | lld:lifeskim |
| pubmed-article:7595699 | lifeskim:mentions | umls-concept:C1554078 | lld:lifeskim |
| pubmed-article:7595699 | lifeskim:mentions | umls-concept:C0332293 | lld:lifeskim |
| pubmed-article:7595699 | lifeskim:mentions | umls-concept:C0231449 | lld:lifeskim |
| pubmed-article:7595699 | pubmed:issue | 10 | lld:pubmed |
| pubmed-article:7595699 | pubmed:dateCreated | 1995-12-4 | lld:pubmed |
| pubmed-article:7595699 | pubmed:abstractText | To assess the effect of treatment intensification and that of extended intrathecal methotrexate substitution for cranial irradiation in intermediate-risk acute lymphoblastic leukemia (ALL) children treated with a Berlin-Frankfurt-Münster (BFM)-based intensive chemotherapy. | lld:pubmed |
| pubmed-article:7595699 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7595699 | pubmed:language | eng | lld:pubmed |
| pubmed-article:7595699 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7595699 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:7595699 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7595699 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7595699 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7595699 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7595699 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7595699 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7595699 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7595699 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7595699 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7595699 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:7595699 | pubmed:month | Oct | lld:pubmed |
| pubmed-article:7595699 | pubmed:issn | 0732-183X | lld:pubmed |
| pubmed-article:7595699 | pubmed:author | pubmed-author:MinieroRR | lld:pubmed |
| pubmed-article:7595699 | pubmed:author | pubmed-author:BassoGG | lld:pubmed |
| pubmed-article:7595699 | pubmed:author | pubmed-author:MessinaCC | lld:pubmed |
| pubmed-article:7595699 | pubmed:author | pubmed-author:MoriP GPG | lld:pubmed |
| pubmed-article:7595699 | pubmed:author | pubmed-author:AricòMM | lld:pubmed |
| pubmed-article:7595699 | pubmed:author | pubmed-author:ConterVV | lld:pubmed |
| pubmed-article:7595699 | pubmed:author | pubmed-author:TestiA MAM | lld:pubmed |
| pubmed-article:7595699 | pubmed:author | pubmed-author:RizzariCC | lld:pubmed |
| pubmed-article:7595699 | pubmed:author | pubmed-author:ValsecchiM... | lld:pubmed |
| pubmed-article:7595699 | pubmed:author | pubmed-author:ColellaRR | lld:pubmed |
| pubmed-article:7595699 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:7595699 | pubmed:volume | 13 | lld:pubmed |
| pubmed-article:7595699 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:7595699 | pubmed:authorsComplete | N | lld:pubmed |
| pubmed-article:7595699 | pubmed:pagination | 2497-502 | lld:pubmed |
| pubmed-article:7595699 | pubmed:dateRevised | 2007-11-15 | lld:pubmed |
| pubmed-article:7595699 | pubmed:meshHeading | pubmed-meshheading:7595699-... | lld:pubmed |
| pubmed-article:7595699 | pubmed:meshHeading | pubmed-meshheading:7595699-... | lld:pubmed |
| pubmed-article:7595699 | pubmed:meshHeading | pubmed-meshheading:7595699-... | lld:pubmed |
| pubmed-article:7595699 | pubmed:meshHeading | pubmed-meshheading:7595699-... | lld:pubmed |
| pubmed-article:7595699 | pubmed:meshHeading | pubmed-meshheading:7595699-... | lld:pubmed |
| pubmed-article:7595699 | pubmed:meshHeading | pubmed-meshheading:7595699-... | lld:pubmed |
| pubmed-article:7595699 | pubmed:meshHeading | pubmed-meshheading:7595699-... | lld:pubmed |
| pubmed-article:7595699 | pubmed:meshHeading | pubmed-meshheading:7595699-... | lld:pubmed |
| pubmed-article:7595699 | pubmed:meshHeading | pubmed-meshheading:7595699-... | lld:pubmed |
| pubmed-article:7595699 | pubmed:meshHeading | pubmed-meshheading:7595699-... | lld:pubmed |
| pubmed-article:7595699 | pubmed:meshHeading | pubmed-meshheading:7595699-... | lld:pubmed |
| pubmed-article:7595699 | pubmed:meshHeading | pubmed-meshheading:7595699-... | lld:pubmed |
| pubmed-article:7595699 | pubmed:meshHeading | pubmed-meshheading:7595699-... | lld:pubmed |
| pubmed-article:7595699 | pubmed:meshHeading | pubmed-meshheading:7595699-... | lld:pubmed |
| pubmed-article:7595699 | pubmed:meshHeading | pubmed-meshheading:7595699-... | lld:pubmed |
| pubmed-article:7595699 | pubmed:meshHeading | pubmed-meshheading:7595699-... | lld:pubmed |
| pubmed-article:7595699 | pubmed:meshHeading | pubmed-meshheading:7595699-... | lld:pubmed |
| pubmed-article:7595699 | pubmed:meshHeading | pubmed-meshheading:7595699-... | lld:pubmed |
| pubmed-article:7595699 | pubmed:meshHeading | pubmed-meshheading:7595699-... | lld:pubmed |
| pubmed-article:7595699 | pubmed:meshHeading | pubmed-meshheading:7595699-... | lld:pubmed |
| pubmed-article:7595699 | pubmed:meshHeading | pubmed-meshheading:7595699-... | lld:pubmed |
| pubmed-article:7595699 | pubmed:meshHeading | pubmed-meshheading:7595699-... | lld:pubmed |
| pubmed-article:7595699 | pubmed:meshHeading | pubmed-meshheading:7595699-... | lld:pubmed |
| pubmed-article:7595699 | pubmed:meshHeading | pubmed-meshheading:7595699-... | lld:pubmed |
| pubmed-article:7595699 | pubmed:meshHeading | pubmed-meshheading:7595699-... | lld:pubmed |
| pubmed-article:7595699 | pubmed:meshHeading | pubmed-meshheading:7595699-... | lld:pubmed |
| pubmed-article:7595699 | pubmed:year | 1995 | lld:pubmed |
| pubmed-article:7595699 | pubmed:articleTitle | Extended intrathecal methotrexate may replace cranial irradiation for prevention of CNS relapse in children with intermediate-risk acute lymphoblastic leukemia treated with Berlin-Frankfurt-Münster-based intensive chemotherapy. The Associazione Italiana di Ematologia ed Oncologia Pediatrica. | lld:pubmed |
| pubmed-article:7595699 | pubmed:affiliation | Department of Pediatrics, University of Milano, Italy. | lld:pubmed |
| pubmed-article:7595699 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:7595699 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:7595699 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| pubmed-article:7595699 | pubmed:publicationType | Multicenter Study | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:7595699 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:7595699 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:7595699 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:7595699 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:7595699 | lld:pubmed |
